Fredy Nehme

@NehmeFredy

Gastroenterology fellow. MS Bioinformatics candidate. Views expressed are mine.

Kansas City, MO
Vrijeme pridruživanja: siječanj 2019.
21 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @NehmeFredy

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NehmeFredy

  1. proslijedio/la je Tweet
    27. lis 2019.

    Introducing The EndoTitans!! Contestants in a fierce competition of skills making its debut at thanks to ACG’s Dr. Seth Gross, Chair of Educational Affairs

    4 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    21. lis 2019.

    THIS JUST IN: Stelara (ustekinumab) received approval for the treatment of moderately to severely active . Same dosing as in . A great new option for our UC patients. Highlighted new label below. ⬇️⬇️

    82 proslijeđena tweeta 196 korisnika označava da im se sviđa
    Poništi
  3. proslijedio/la je Tweet
    21. ruj 2019.

    Peter Kahrilas (Northwestern): Relative potency of PPIs

    27 proslijeđenih tweetova 67 korisnika označava da im se sviđa
    Poništi
  4. proslijedio/la je Tweet
    19. ruj 2019.

    After a stellar presentation from at the Fellowship session, we were able to recruit ⭐️ , to our research team, while will join us for all our Endoscopy in Liver dx projects

    , , i još njih 5
    4 proslijeđena tweeta 27 korisnika označava da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    9. ruj 2019.

    To all my friends I asked these questions 10 years ago and still have no answer to ONE!!! Waiting for your input 😁

    19 replies 65 proslijeđenih tweetova 174 korisnika označavaju da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    4. ruj 2019.

    De-escalation of IBD Therapy: When, Who, and How?

    10 proslijeđenih tweetova 16 korisnika označava da im se sviđa
    Poništi
  7. proslijedio/la je Tweet
    5. kol 2019.

    Use of statins and azathioprine associated w/ reduced risk of death and liver transplantation in patients w/ primary sclerosing cholangitis

    6 proslijeđenih tweetova 3 korisnika označavaju da im se sviđa
    Poništi
  8. proslijedio/la je Tweet
    7. srp 2019.

    Pancreatic exocrine insufficiency: causes, consequences, diagnosis and treatment. Don´t miss this twitter thread

    6 replies 97 proslijeđenih tweetova 125 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  9. proslijedio/la je Tweet
    17. srp 2019.

    If you do colonoscopy in the US this story is very important. Growing evidence to support LONGER intervals to repeat colo when 1-2 adenomas are found. 5 years is too short.

    What to do about those low-risk adenomas (surveillance looking less necessary):
    1 reply 6 proslijeđenih tweetova 15 korisnika označava da im se sviđa
    Poništi
  10. proslijedio/la je Tweet
    16. srp 2019.

    Listen to the podcast of “Risk of bacterial exposure to the endoscopist’s face during endoscopy” by Johnston et al.

    5 proslijeđenih tweetova 4 korisnika označavaju da im se sviđa
    Poništi
  11. proslijedio/la je Tweet
    24. lip 2019.
    Odgovor korisnicima i sljedećem broju korisnika:

    Here are the '9 steps' to success in endoscopy that I share with our 1st year fellows . Note that the most important items are all about communication, not technical skills.

    24 proslijeđena tweeta 56 korisnika označava da im se sviđa
    Poništi
  12. 23. svi 2019.

    In a RCT including ~ 1000 patients, no statistically significant benefit was found for prophylactic hemoclip placement for polyps > 1 cm in terms of delayed post-polypectomy bleeding for up to 30 days

    Hemoclips may not reduce post-polypectomy bleeding, which questions the common practice of using hemoclips during polypectomy, according to data 's presented at
    Poništi
  13. 21. svi 2019.

    VARSITY: Entyvio beats Humira in ulcerative colitis with higher clinical and endoscopic remission at 52 weeks

    1 korisnik označava da mu se sviđa
    Poništi
  14. 2. svi 2019.

    Finally Medicaid beneficiaries in Kansas infected with Hepatitis C will be able to receive treatment regardless of fibrosis stage.

    Poništi
  15. proslijedio/la je Tweet
    2. svi 2019.

    Patients with recurrent spend a lot less time in the hospital in the year after FMT.

    2 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  16. proslijedio/la je Tweet
    25. ožu 2019.

    New : β blockers to prevent decompensation of in patients with clinically significant (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial -

    5 proslijeđenih tweetova 10 korisnika označava da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    22. ožu 2019.

    AI in GI in the Red Journal Artificial Intelligence-Assisted Gastroenterology— Promises and Pitfalls Ruffle, et al. Read:

    7 proslijeđenih tweetova 7 korisnika označava da im se sviđa
    Poništi
  18. proslijedio/la je Tweet
    13. ožu 2019.

    A randomized trial of deep learning reduced blind spots during endoscopy 4-fold These are the kind of trials we need for proof, of which there are v few. From China's H/T

    85 proslijeđenih tweetova 146 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi

@NehmeFredy još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·